News

Foveal abnormalities determined by OCTA in children with history of ROP

OCTA a hope for diagnosing, managing ophthalmic diseases

ByLynda Charters

May 12th 2020

Simplicity key to diagnosing, treating vitreoretinal lymphoma

ByLynda Charters

May 11th 2020

Scleral melts: Patching ultimately may prove to be unnecessary

ByLynda Charters

May 7th 2020

Battling endophthalmitis: New bugs, new technologies, new drugs

ByLynda Charters

May 5th 2020

Ultra-widefield imaging adding depth to pediatric ophthalmology

ByLynda Charters

May 4th 2020

Social distancing eye exams

ByJon Carter

May 3rd 2020

COVID-19 pandemic may be a ‘black swan’ event for investors

ByJohn J. Grande, CFP; Traudy F. Grande, CFP; and John S. Grande, CFP

May 1st 2020

Breathing through COVID-19: First-hand account in protecting one’s health, finances

ByJohn J. Grande, CFP,Traudy F. Grande, CFP,John S. Grande, CFP

May 1st 2020

Genetic analysis could predict myopia in children

ByLaird Harrison

May 1st 2020

On the bright side .... looking for the positive amid pandemic's many negatives

ByPeter J. McDonnell, MD

April 26th 2020

COVID-19: Sun Pharmaceuticals business update

ByMark Hagler

April 23rd 2020

Genetic variants linked with onset, progression of POAG

ByLynda Charters

April 23rd 2020

Show me the patients: Patient satisfaction, not surgical landmarks or chart indices, mark of success

ByArun C. Gulani, MD

April 20th 2020

Tear tests in eye care: Use, reimbursement outlined

ByMichael Berg

April 20th 2020

COVID-19: BELKIN Laser CEO offers company update

ByAlex Delaney-Gesing

April 17th 2020

Overcoming blindness: Forging a path through research

ByLynda Charters

April 17th 2020

PACK-CXL researchers continue to clear hurdles of topical drugs

ByLynda Charters

April 15th 2020

Echoes of history: COVID-19 pandemic stirs memories, tests our mettle

ByPeter J. McDonnell, MD

April 15th 2020

Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)

ByAlex Delaney-Gesing

April 14th 2020

Glaucoma 360: Glaucoma devices update with Victor Chan, MB, MS (Santen Inc)

ByAlex Delaney-Gesing

April 13th 2020

Technology 'perfect' for pediatric neuro-ophthalmology diagnoses

ByLynda Charters

April 13th 2020

Diagnosing LSCD noninvasively: SD-OCT preferred technology

ByLynda Charters

April 10th 2020

COVID-19: How neuro-ophthalmology is acclimating in the pandemic era

ByAlex Delaney-Gesing

April 9th 2020

Telemedicine forum helps ophthalmologists stay connected amid COVID-19

BySheryl Stevenson

April 9th 2020

Coronavirus response: Generations react differently to COVID-19

ByPeter J. McDonnell, MD

April 9th 2020

COVID 19: Tips for protecting patients/staff

ByAlex Delaney-Gesing

April 8th 2020

Surgical intervention for childhood glaucoma

ByLynda Charters

April 8th 2020

COVID-19: Know your financial options with the CARES Act

ByJohn J. Grande, CFP; Traudy F. Grande, CFP; and John S. Grande, CFP

April 6th 2020

Researchers eye cure, diagnostics for adenoviral conjunctivitis

ByLynda Charters

April 5th 2020

COVID-19: Putting safety measures into practice

ByAlex Delaney-Gesing

April 3rd 2020

News

OCTA a hope for diagnosing, managing ophthalmic diseases

Simplicity key to diagnosing, treating vitreoretinal lymphoma

Scleral melts: Patching ultimately may prove to be unnecessary

Battling endophthalmitis: New bugs, new technologies, new drugs

Ultra-widefield imaging adding depth to pediatric ophthalmology

Social distancing eye exams

COVID-19 pandemic may be a ‘black swan’ event for investors

Breathing through COVID-19: First-hand account in protecting one’s health, finances

Genetic analysis could predict myopia in children

On the bright side .... looking for the positive amid pandemic's many negatives

COVID-19: Sun Pharmaceuticals business update

Genetic variants linked with onset, progression of POAG

Show me the patients: Patient satisfaction, not surgical landmarks or chart indices, mark of success

Tear tests in eye care: Use, reimbursement outlined

COVID-19: BELKIN Laser CEO offers company update

Overcoming blindness: Forging a path through research

PACK-CXL researchers continue to clear hurdles of topical drugs

Echoes of history: COVID-19 pandemic stirs memories, tests our mettle

Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)

Glaucoma 360: Glaucoma devices update with Victor Chan, MB, MS (Santen Inc)

Technology 'perfect' for pediatric neuro-ophthalmology diagnoses

Diagnosing LSCD noninvasively: SD-OCT preferred technology

COVID-19: How neuro-ophthalmology is acclimating in the pandemic era

Telemedicine forum helps ophthalmologists stay connected amid COVID-19

Coronavirus response: Generations react differently to COVID-19

COVID 19: Tips for protecting patients/staff

Surgical intervention for childhood glaucoma

COVID-19: Know your financial options with the CARES Act

Researchers eye cure, diagnostics for adenoviral conjunctivitis

COVID-19: Putting safety measures into practice

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials

Sandoz Canada launches aflibercept biosimilar, Enzeevum

Noninvasive LED light therapy shows long-term safety in early cataract clinical follow-up

AMD and low vision awareness month: Using the MTII to evaluate progression of GA

The Residency Report: PreserFlo microshunt vs trabeculectomy—five-year trial insights